ID   TESK1_HUMAN             Reviewed;         626 AA.
AC   Q15569; Q8IXZ8;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 2.
DT   15-MAR-2017, entry version 164.
DE   RecName: Full=Dual specificity testis-specific protein kinase 1;
DE            EC=2.7.12.1;
DE   AltName: Full=Testicular protein kinase 1;
GN   Name=TESK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Hepatoma;
RX   PubMed=8537404; DOI=10.1074/jbc.270.52.31331;
RA   Toshima J., Ohashi K., Okano I., Nunoue K., Kishioka M., Kuma K.,
RA   Miyata T., Hirai M., Baba T., Mizuno K.;
RT   "Identification and characterization of a novel protein kinase, TESK1,
RT   specifically expressed in testicular germ cells.";
RL   J. Biol. Chem. 270:31331-31337(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH SPRY4.
RX   PubMed=12027893; DOI=10.1046/j.1432-1033.2002.02921.x;
RA   Leeksma O.C., van Achterberg T.A.E., Tsumura Y., Toshima J.,
RA   Eldering E., Kroes W.G.M., Mellink C., Spaargaren M., Mizuno K.,
RA   Pannekoek H., de Vries C.J.M.;
RT   "Human sprouty 4, a new ras antagonist on 5q31, interacts with the
RT   dual specificity kinase TESK1.";
RL   Eur. J. Biochem. 269:2546-2556(2002).
RN   [6]
RP   VARIANT [LARGE SCALE ANALYSIS] TYR-539.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [7]
RP   VARIANTS [LARGE SCALE ANALYSIS] TYR-539 AND SER-574.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Dual specificity protein kinase activity catalyzing
CC       autophosphorylation and phosphorylation of exogenous substrates on
CC       both serine/threonine and tyrosine residues. Probably plays a
CC       central role at and after the meiotic phase of spermatogenesis (By
CC       similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- ENZYME REGULATION: Activated by autophosphorylation on Ser-220.
CC       Kinase activity is inhibited by SPRED1 (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with TAOK2; leading to inhibit TAOK2 activity.
CC       Interacts with SPRED1; leading to inhibit activity (By
CC       similarity). Interacts with SPRY4. {ECO:0000250,
CC       ECO:0000269|PubMed:12027893}.
CC   -!- INTERACTION:
CC       Q9C004:SPRY4; NbExp=4; IntAct=EBI-354852, EBI-354861;
CC   -!- DOMAIN: The extracatalytic C-terminal part is highly rich in
CC       proline residues.
CC   -!- PTM: Autophosphorylated on serine and tyrosine residues.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D50863; BAA09459.1; -; mRNA.
DR   EMBL; AL357874; CAI13441.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58375.1; -; Genomic_DNA.
DR   EMBL; BC038448; AAH38448.1; -; mRNA.
DR   EMBL; BC067130; AAH67130.1; -; mRNA.
DR   CCDS; CCDS6580.1; -.
DR   RefSeq; NP_001305159.1; NM_001318230.1.
DR   RefSeq; NP_006276.2; NM_006285.2.
DR   UniGene; Hs.708096; -.
DR   ProteinModelPortal; Q15569; -.
DR   SMR; Q15569; -.
DR   BioGrid; 112875; 12.
DR   IntAct; Q15569; 6.
DR   MINT; MINT-210342; -.
DR   STRING; 9606.ENSP00000338127; -.
DR   BindingDB; Q15569; -.
DR   ChEMBL; CHEMBL5604; -.
DR   GuidetoPHARMACOLOGY; 2239; -.
DR   iPTMnet; Q15569; -.
DR   PhosphoSitePlus; Q15569; -.
DR   BioMuta; TESK1; -.
DR   DMDM; 209572684; -.
DR   PaxDb; Q15569; -.
DR   PeptideAtlas; Q15569; -.
DR   PRIDE; Q15569; -.
DR   DNASU; 7016; -.
DR   Ensembl; ENST00000336395; ENSP00000338127; ENSG00000107140.
DR   Ensembl; ENST00000620767; ENSP00000481045; ENSG00000107140.
DR   GeneID; 7016; -.
DR   KEGG; hsa:7016; -.
DR   UCSC; uc003zxa.4; human.
DR   CTD; 7016; -.
DR   GeneCards; TESK1; -.
DR   HGNC; HGNC:11731; TESK1.
DR   MIM; 601782; gene.
DR   neXtProt; NX_Q15569; -.
DR   OpenTargets; ENSG00000107140; -.
DR   PharmGKB; PA36448; -.
DR   eggNOG; ENOG410IF1S; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00530000063025; -.
DR   HOGENOM; HOG000231415; -.
DR   HOVERGEN; HBG058204; -.
DR   InParanoid; Q15569; -.
DR   KO; K08841; -.
DR   OMA; KMECEGS; -.
DR   OrthoDB; EOG091G0HLL; -.
DR   PhylomeDB; Q15569; -.
DR   TreeFam; TF318014; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-446388; Regulation of cytoskeletal remodeling and cell spreading by IPP complex components.
DR   SignaLink; Q15569; -.
DR   SIGNOR; Q15569; -.
DR   ChiTaRS; TESK1; human.
DR   GeneWiki; TESK1; -.
DR   GenomeRNAi; 7016; -.
DR   PRO; PR:Q15569; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000107140; -.
DR   CleanEx; HS_TESK1; -.
DR   Genevisible; Q15569; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004871; F:signal transducer activity; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0007283; P:spermatogenesis; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR015782; TESK1.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   PANTHER; PTHR23257:SF555; PTHR23257:SF555; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Kinase; Magnesium; Manganese;
KW   Metal-binding; Methylation; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    626       Dual specificity testis-specific protein
FT                                kinase 1.
FT                                /FTId=PRO_0000086746.
FT   DOMAIN       57    314       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      63     71       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    175    175       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING      86     86       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     220    220       Phosphoserine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     338    338       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:O70146}.
FT   VARIANT     539    539       H -> Y (in breast cancer samples;
FT                                infiltrating ductal carcinoma; somatic
FT                                mutation). {ECO:0000269|PubMed:16959974,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_035638.
FT   VARIANT     574    574       G -> S (in dbSNP:rs55673450).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041213.
FT   CONFLICT     43     43       A -> V (in Ref. 1; BAA09459).
FT                                {ECO:0000305}.
SQ   SEQUENCE   626 AA;  67684 MW;  32F78E5E6AEDB0E5 CRC64;
     MAGERPPLRG PGPGPGEVPG EGPPGPGGTG GGPGRGRPSS YRALRSAVSS LARVDDFHCA
     EKIGAGFFSE VYKVRHRQSG QVMVLKMNKL PSNRGNTLRE VQLMNRLRHP NILRFMGVCV
     HQGQLHALTE YMNGGTLEQL LSSPEPLSWP VRLHLALDIA RGLRYLHSKG VFHRDLTSKN
     CLVRREDRGF TAVVGDFGLA EKIPVYREGA RKEPLAVVGS PYWMAPEVLR GELYDEKADV
     FAFGIVLCEL IARVPADPDY LPRTEDFGLD VPAFRTLVGD DCPLPFLLLA IHCCNLEPST
     RAPFTEITQH LEWILEQLPE PAPLTRTALT HNQGSVARGG PSATLPRPDP RLSRSRSDLF
     LPPSPESPPN WGDNLTRVNP FSLREDLRGG KIKLLDTPSK PVLPLVPPSP FPSTQLPLVT
     TPETLVQPGT PARRCRSLPS SPELPRRMET ALPGPGPPAV GPSAEEKMEC EGSSPEPEPP
     GPAPQLPLAV ATDNFISTCS SASQPWSPRS GPVLNNNPPA VVVNSPQGWA GEPWNRAQHS
     LPRAAALERT EPSPPPSAPR EPDEGLPCPG CCLGPFSFGF LSMCPRPTPA VARYRNLNCE
     AGSLLCHRGH HAKPPTPSLQ LPGARS
//
